Safety results of the enzalutamide expanded access program in the United States and Canada for patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel. Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Joshua, Anthony M
  • Shore, Neal D
  • Saad, Fred
  • Chi, Kim N
  • Olsson, Carl A
  • Emmenegger, Urban
  • Scholz, Mark C
  • Berry, William R
  • Mukherjee, Som
  • Winquist, Eric
  • Haas, Naomi B
  • Hasabou, Nahla
  • Dmuchowski, Carl
  • Perabo, Frank
  • Hirmand, Mohammad
  • Foley, Margaret A
  • Rathkopf, Dana E

publication date

  • May 20, 2014